New obesity and Alzheimer’s disease treatments are keeping Eli Lilly and Company (LLY) at the forefront of equities ...
The Motley Fool on MSN2d
Missed Out on Eli Lilly? This Much Smaller Biotech Has 2 Promising Weight Loss Assets in its PortfolioZealand Pharma is a much smaller healthcare stock than Eli Lilly. It has multiple drug candidates with the potential to ...
Shares of Eli Lilly & Co. LLY rallied 1.83% to $914.57 Friday, on what proved to be an all-around positive trading session ...
The letter follows Rolling Stone’s report that Leonard Leo’s consulting firm has worked for the pharmaceutical giant ...
Investors shouldn't assume that all of the company's future growth is already priced into the stock's valuation.
Wall Street expectations for where Eli Lilly stock is headed this year vary considerably, but some analysts still have faith.
Eli Lilly and Co. (NYSE: LLY) shares are experiencing increased activity Friday afternoon. Here's what you need to know.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback